Scarica l'app Stockscreener
39.92
1.66%
0.65
Dopo l'orario di chiusura:
39.90
-0.02
-0.05%
Precedente Chiudi:
$39.27
Aprire:
$39.34
Volume 24 ore:
191.84K
Relative Volume:
0.42
Capitalizzazione di mercato:
$1.14B
Reddito:
-
Utile/perdita netta:
$-69.47M
Rapporto P/E:
-7.132
EPS:
-5.5973
Flusso di cassa netto:
$-73.92M
1 W Prestazione:
+4.50%
1M Prestazione:
+36.11%
6M Prestazione:
+85.59%
1 anno Prestazione:
+61.49%
Intervallo 1D:
$38.92
$40.00
Intervallo di 1 settimana:
$37.84
$40.35
Portata 52W:
$16.54
$41.70
Lenz Therapeutics Inc Stock (LENZ) Company Profile
Nome
Lenz Therapeutics Inc
Settore
Industria
Telefono
858-925-7000
Indirizzo
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH
Confronta LENZ con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LENZ
Lenz Therapeutics Inc
|
39.92 | 1.12B | 0 | -69.47M | -73.92M | -5.5973 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Lenz Therapeutics Inc Stock (LENZ) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-14 | Ripresa | Piper Sandler | Overweight |
| 2025-03-18 | Iniziato | TD Cowen | Buy |
| 2024-09-27 | Iniziato | Raymond James | Outperform |
| 2024-08-12 | Iniziato | H.C. Wainwright | Buy |
| 2024-04-15 | Iniziato | Leerink Partners | Outperform |
| 2024-04-15 | Iniziato | William Blair | Outperform |
| 2024-04-10 | Iniziato | Citigroup | Buy |
| 2024-03-27 | Iniziato | Piper Sandler | Overweight |
| 2023-02-23 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-02-23 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2023-02-23 | Downgrade | Cowen | Outperform → Market Perform |
| 2023-01-25 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-01-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-01-06 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-06 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-06-17 | Iniziato | BMO Capital Markets | Outperform |
| 2022-04-14 | Iniziato | BTIG Research | Buy |
| 2022-03-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-02-18 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-07-20 | Iniziato | Morgan Stanley | Overweight |
| 2021-07-20 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Lenz Therapeutics Inc Borsa (LENZ) Ultime notizie
Key metrics from LENZ Therapeutics Inc.’s quarterly dataEarnings Trend Report & Weekly Breakout Watchlists - Newser
Institutional scanner results for LENZ Therapeutics Inc.2025 Trading Recap & Growth Oriented Trade Recommendations - Newser
LENZ Therapeutics: A Case Study in Strategic Execution and Market Readiness - AInvest
Transcript : LENZ Therapeutics, Inc. Presents at Citi's Biopharma Back to School Conference, Sep-03-2025 09 - MarketScreener
Analyzing LENZ Therapeutics Inc. with multi timeframe charts2025 Key Lessons & Step-by-Step Trade Execution Guides - Newser
LENZ Therapeutics Inc. stock volume spike explainedJuly 2025 Trends & Community Consensus Picks - Newser
Can swing trading help recover from LENZ Therapeutics Inc. lossesM&A Rumor & Safe Entry Zone Identification - Newser
What momentum shifts mean for LENZ Therapeutics Inc.Forecast Cut & Free Growth Oriented Trading Recommendations - Newser
Will LENZ Therapeutics Inc. stock go up soonJuly 2025 Volume & Expert Approved Momentum Ideas - Newser
Will LENZ Therapeutics Inc. rebound enough to break evenJuly 2025 Short Interest & AI Based Buy and Sell Signals - Newser
Backtesting results for LENZ Therapeutics Inc. trading strategiesJuly 2025 Catalysts & Smart Allocation Stock Reports - Newser
Relative strength of LENZ Therapeutics Inc. in sector analysisWeekly Gains Summary & High Win Rate Trade Alerts - Newser
Analyzing LENZ Therapeutics Inc. with risk reward ratio chartsPortfolio Growth Summary & Community Supported Trade Ideas - Newser
How to manage a losing position in LENZ Therapeutics Inc.July 2025 Selloffs & Smart Investment Allocation Insights - Newser
Will LENZ Therapeutics Inc. stock recover after recent dropIndex Update & Free Growth Oriented Trading Recommendations - Newser
Will LENZ Therapeutics Inc. outperform during market rallies2025 Volatility Report & Weekly Watchlist for Consistent Profits - khodrobank.com
Can LENZ Therapeutics Inc. expand its profit marginsJobs Report & Fast Momentum Stock Entry Tips - khodrobank.com
Earnings visualization tools for LENZ Therapeutics Inc.Market Movers & Accurate Buy Signal Notifications - Newser
Real time social sentiment graph for LENZ Therapeutics Inc.Product Launch & Technical Buy Zone Confirmation - Newser
What’s the beta of LENZ Therapeutics Inc. stock2025 Trading Recap & Stepwise Trade Signal Implementation - khodrobank.com
Will LENZ Therapeutics Inc. benefit from government policyWeekly Trade Analysis & Real-Time Price Movement Reports - khodrobank.com
Why LENZ Therapeutics Inc. is moving todayWeekly Investment Report & Verified Stock Trade Ideas - Newser
What’s the profit margin of LENZ Therapeutics Inc.Gold Moves & Low Volatility Stock Suggestions - khodrobank.com
Multi factor analysis applied to LENZ Therapeutics Inc.2025 Technical Overview & Safe Entry Trade Signal Reports - Newser
Real time breakdown of LENZ Therapeutics Inc. stock performanceTrade Analysis Report & Real-Time Volume Surge Alerts - Newser
Does LENZ Therapeutics Inc. outperform in volatile markets2025 Stock Rankings & AI Forecast Swing Trade Picks - khodrobank.com
What momentum shifts mean for LENZ Therapeutics IncWeekly Gains Report & Real-Time Volume Analysis - Newser
LENZ Therapeutics Inc. stock outlook for YEAR2025 Risk Factors & Safe Capital Allocation Plans - Newser
Will LENZ Therapeutics Inc. benefit from macro trendsNew Guidance & Free Technical Pattern Based Buy Signals - Newser
LENZ Therapeutics Inc.’s volatility index tracking explainedEarnings Risk Summary & Fast Entry High Yield Tips - Newser
Will LENZ Therapeutics Inc. price bounce be sustainableQuarterly Profit Review & Short-Term High Return Strategies - Newser
Tick level data insight on LENZ Therapeutics Inc. volatility2025 Key Highlights & Daily Profit Maximizing Trade Tips - Newser
LENZ Therapeutics Inc. Bounces Off Moving Average Support getLinesFromResByArray error: size == 0 - sisaissue.com
Full technical analysis of LENZ Therapeutics Inc. stockInflation Watch & Reliable Intraday Trade Plans - Newser
Published on: 2025-08-31 12:22:12 - Newser
LENZ Therapeutics shares climb as FDA review of presbyopia treatment stays on schedule - MSN
Trend analysis for LENZ Therapeutics Inc. this weekJuly 2025 Trends & Risk Managed Investment Signals - Newser
Should you hold or exit LENZ Therapeutics Inc. nowPortfolio Gains Summary & Daily Price Action Insights - Newser
LENZ Therapeutics Inc. Attempts Reversal From Key SupportJuly 2025 Levels & Technical Entry and Exit Alerts - beatles.ru
Lenz Therapeutics Inc Azioni (LENZ) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lenz Therapeutics Inc Azioni (LENZ) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Versant Venture Capital VI, L. | 10% Owner |
Aug 26 '25 |
Sale |
39.01 |
47,443 |
1,850,891 |
1,274,197 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 22 '25 |
Sale |
40.15 |
26,161 |
1,050,392 |
1,374,059 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 25 '25 |
Sale |
39.54 |
25,818 |
1,020,888 |
924,175 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 26 '25 |
Sale |
39.01 |
23,368 |
911,655 |
900,807 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 22 '25 |
Sale |
40.15 |
12,885 |
517,356 |
949,993 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 15 '25 |
Sale |
39.50 |
145,051 |
5,729,514 |
1,430,848 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 15 '25 |
Sale |
39.50 |
69,949 |
2,762,986 |
977,963 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 18 '25 |
Sale |
38.56 |
30,628 |
1,181,049 |
1,400,220 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 18 '25 |
Sale |
38.56 |
15,085 |
581,694 |
962,878 |
| Versant Venture Capital VI, L. | 10% Owner |
Jul 10 '25 |
Sale |
34.00 |
191,376 |
6,506,784 |
1,575,899 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):